http://web.archive.org/web/20140823085909id_/http://www.dailymail.co.uk/news/article-2726111/Cannabis-based-medicine-multiple-sclerosis-patients-available-NHS-Wales.html

by @entity0 for @entity1 @entity2 , a mouth spray designed to alleviate the symptoms of multiple sclerosis , will be available on the @entity6 in @entity7 a cannabis - based drug designed to alleviate the symptoms of multiple sclerosis is to be made available on prescription in @entity7 , health officials have confirmed			1
@entity2 , an oral spray made from two chemical extracts from cannabis plants , has been approved for used by the @entity16			1
@entity7 ' health minister @entity17 said he hoped the spray would help ease the suffering of those who have to live with the reality of ms. the decision was welcomed by the @entity24 , which said it hoped the decision would prompt @entity26 , @entity27 and @entity28 to follow suit			1
charity director @entity30 , said : ' we are extremely pleased that people with @entity33 in @entity7 will finally have better access to @entity2			0
' as a charity we have campaigned over a long period for @entity2 to be widely available because of the significant impact that @entity33 spasticity can have on daily activities			0
' we just hope that this recommendation will now lead to @entity2 being more easily accessible in the rest of the @entity41			2
' @entity2 is the first cannabis - based medicine to be licensed in the @entity41 and contains delta - 9 tetrahydrocannabinol ( @entity45 ) and cannabidiol ( @entity47 ) passing @entity2 to someone else , unless that person is lawfully entitled to possess the drug , is a criminal offence			1
a statement about the drug on the @entity24 's website says : ' as @entity2 is derived from cannabis , there were initial concerns that it might cause drug dependence , be psychoactive or cause withdrawal symptoms			2
' however , studies into long - term use of @entity2 in people with @entity33 showed that sudden discontinuation of treatment did not result in any significant withdrawal - like symptoms although some people reported temporary changes in their sleeping patterns , mood or appetite following discontinuation			0
@entity2 is based on two extracts from cannabis plants and is the first cannabis - based medicine to be licenced anywhere in the @entity41 ' the lack of withdrawal symptoms suggests that dependence on the treatment is highly unlikely			1
in addition , @entity2 did not affect cognition ( thinking or memory ) or induce any mental health problems at the doses used			0
' @entity7 health minister professor @entity17 said : ' following the appraisal of @entity2 by the @entity16 , i am pleased to announce we will be making the medicine available on the @entity6 to those who need it			0
' i hope this decision will help ease the suffering of some of those who have to live with the reality of @entity33 every day			0

@entity2 is mouth spray based on two extracts from cannabis plants
it is designed to help alleviate the symptoms of multiple sclerosis
@entity24 hails move and wants rest of @entity41 to follow suit

@entity17:Drakeford
@entity2:Sativex
@entity1:MailOnline
@entity0:Chris Pleasance
@entity7:Wales
@entity6:Welsh NHS
@entity24:Multiple Sclerosis Trust
@entity16:All Wales Medicines Strategy Group
@entity28:Northern Ireland
@entity33:MS
@entity45:THC
@entity47:CBD
@entity41:UK
@entity26:England
@entity30:Amy Bowen
@entity27:Scotland